SCHEMBL4159030

SCHEMBL4159030

CN(C(=O)N(Cc1ccccc1)C(=O)c1c(F)cccc1F)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.45
HDAC4 P56524 3/20 0.38
HDAC6 Q9UBN7 3/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
RAB9A P51151 1/20 0.38
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 1/20 0.37
HPGD P15428 2/20 0.37
GAA P10253 1/20 0.37
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
CYP2C19 P33261 1/20 0.35
MLYCD O95822 1/20 0.35
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4150006 0.89 MEN1 (0.43) TDP1KMT2AMEN1HPGDGAA
SCHEMBL4166881 0.89 MEN1 (0.41) KMT2AMEN1RAB9AHPGDALDH1A1
SCHEMBL4158385 0.89 CYP3A4 (0.43) KMT2ARAB9AALDH1A1LMNAMAPT
SCHEMBL4150962 0.88 TDP1 (0.37) TDP1KMT2ARAB9AHPGDGAA
SCHEMBL4157996 0.87 RORC (0.35) TDP1LMNAMAPTTSHRMAPK1
SCHEMBL4142662 0.86 RORC (0.34) TDP1LMNAMAPTTSHRMAPK1
SCHEMBL4159011 0.85 RAB9A (0.45) TDP1KMT2AMEN1RAB9AALDH1A1
SCHEMBL5310973 0.85 TDP1 (0.41) TDP1HDAC4HDAC6KMT2AMEN1
SCHEMBL13774522 0.85 MAPT (0.35) TDP1KDM4ELMNAMAPTTSHR
SCHEMBL4166771 0.85 RXFP1 (0.36) KMT2AMEN1HPGDGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 TDP1 1690/4885HDAC4 2172/4885HDAC6 960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.